{"schema_version":"1.0.0","id":"se:pmod-2025-1","jurisdiction":"se","lang":"sv","judgment_class":"D","text_included":false,"text_note":"Full text is read from the official source. This record carries structured metadata and the text fingerprint.","word_count":6975,"cites":["C-130/11","C-119/22","C-49/22","C-322/10","C-443/12","C-73/18","C-673/18","C-392/97"],"sha256":"959ebd8475534553c76132d9c38008f9f6caf9151b8ddf444276566c38c5578c","source_url":"https://rattspraxis.etjanst.domstol.se/api/v1/publiceringar/47a96677-901b-4cc3-a373-0e84090d1e2e","fetched_at":"2026-10-26T12:24:49.216+00:00","full_text_view":"https://legal.exploreworldai.com/api/public/v1/full-judgment/pmod-2025-1?view=full","risk_graph":"https://legal.exploreworldai.com/api/public/v1/risk?id=se:pmod-2025-1","relations_graph":"https://legal.exploreworldai.com/api/public/v1/relations?id=se:pmod-2025-1","agent":"https://legal.exploreworldai.com/api/public/v1/se-praxis/agent?id=se:pmod-2025-1","ref":"PMÖD 2025:1","court":"Patent- och marknadsöverdomstolen","decided":"2025-02-25","provisions":["Artikel 3 b i Europaparlamentets och rådets förordning (EG) nr 469/2009 av den 6 maj 2009 om tilläggsskydd för läkemedel","Artikel 3 d i Europaparlamentets och rådets förordning (EG) nr 469/2009 av den 6 maj 2009 om tilläggsskydd för läkemedel"],"source":"NovaCopilot"}